Related Experiment Video
Updated: Jan 16, 2026
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
The Relationship Between the Fibrinogen-to-Albumin Ratio and Short-Term Mortality in Chinese Patients With Chronic
Lei Lei Guo1, Ping Liu2, Li Na Cai1
1Department of Cardiology, Jiangyou People's Hospital, Jiangyou 621700, Sichuan, China.
Insights
The fibrinogen-to-albumin ratio (FAR) is linked to increased short-term mortality in heart failure patients. Higher FAR levels indicate a greater risk of death within 28 days and 3 months.
Area of Science:
- Cardiology
- Biomarkers
- Prognostics
Background:
- Limited evidence exists on the fibrinogen-to-albumin ratio (FAR) in heart failure prognosis.
- Previous studies suggest FAR is associated with coronary heart disease prognosis.
- This study investigates the FAR's role in predicting short-term mortality in heart failure.
Purpose of the Study:
- To examine the association between the fibrinogen-to-albumin ratio (FAR) and short-term mortality in heart failure patients.
- To determine the predictive accuracy of FAR for 28-day and 3-month mortality.
- To explore the relationship between FAR and mortality using logistic regression and ROC analysis.
Main Methods:
- Retrospective cohort study of 1880 heart failure patients hospitalized between December 2016 and June 2019.
- Analysis of clinical data, focusing on the fibrinogen-to-albumin ratio (FAR) as the primary exposure.
- Multivariate logistic regression, ROC curves, and sensitivity analyses were used to assess mortality prediction.
Main Results:
- A one standard deviation increase in FAR correlated with a 45% rise in 28-day mortality (OR=1.45).
- Elevated FAR levels (> 0.126) were significantly associated with increased 28-day and 3-month mortality.
- The optimal FAR cutoff for predicting mortality was 0.156, with an AUC of 0.654 for 28-day mortality.
Conclusions:
- The fibrinogen-to-albumin ratio (FAR) is positively correlated with short-term mortality in Chinese heart failure patients.
- FAR demonstrates potential as a prognostic biomarker for heart failure.
- Further research is needed to elucidate the pathophysiological mechanisms and therapeutic implications of FAR in heart failure.
Abstract:
Background: Recent studies have identified an association between the fibrinogen-to-albumin ratio (FAR) and the prognosis of coronary heart disease; however, evidence regarding its significance in heart failure patients remains limited. This study aims to examine the relationship between the FAR and short-term mortality among individuals with heart failure. Methods: In this retrospective cohort study, we conducted an analysis of clinical data from patients with heart failure who were hospitalized at Zigong Fourth People's Hospital from December 2016 to June 2019. The primary exposure variable was the FAR, while the outcomes of interest were mortality rates at 28 days and 3 months. Multivariate logistic regression evaluated FAR's independent association with short-term mortality, with predictive accuracy assessed via ROC curves and subgroup consistency through stratified analyses. Furthermore, smooth curve fitting was utilized to investigate the linear relationship, and a series of sensitivity analyses were conducted to validate the robustness of the findings. Results: The analysis included 1880 participants, of whom 58.1% were females and 54.1% were aged 60-80 years. Our study showed that a one standard deviation rise in the FAR was linked to a 45% increase in 28-day mortality (OR = 1.45, 95% CI = 1.02-2.06, p=0.04) after adjusting for potential confounding factors. The 28-day mortality rate was markedly elevated in the high FAR group (FAR > 0.126) compared to the low FAR group (OR = 4.01, 95% CI = 1.17-13.82, p=0.028). Comparable findings were noted at the 3-month mark. There were no significant interactions found in the subgroup analysis. A linear association was identified between FAR and short-term mortality. The optimal FAR cutoff value for predicting 28-day mortality was 0.156 (sensitivity 68.0%, specificity 59.4%, AUC = 0.654), while for 3-month mortality, it was 0.156 (sensitivity 68.0%, specificity 58.3%, AUC = 0.647). Sensitivity analyses corroborated the robustness of our findings. Conclusion: A positive correlation exists between the FAR and short-term mortality among Chinese patients with heart failure. These findings underscore the necessity for further investigation into the underlying pathophysiological mechanisms and potential therapeutic interventions associated with FAR in the context of heart failure.
Related Concept Videos
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
01:22Heart Failure VI: Adjunct Therapies